138 related articles for article (PubMed ID: 10963632)
1. Effects of myocardial edema on the development of myocardial interstitial fibrosis.
Davis KL; Laine GA; Geissler HJ; Mehlhorn U; Brennan M; Allen SJ
Microcirculation; 2000 Aug; 7(4):269-80. PubMed ID: 10963632
[TBL] [Abstract][Full Text] [Related]
2. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
3. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats.
Deten A; Hölzl A; Leicht M; Barth W; Zimmer HG
J Mol Cell Cardiol; 2001 Jun; 33(6):1191-207. PubMed ID: 11444923
[TBL] [Abstract][Full Text] [Related]
4. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M
Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654
[TBL] [Abstract][Full Text] [Related]
5. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
[TBL] [Abstract][Full Text] [Related]
6. Gene transfection of hepatocyte growth factor attenuates the progression of cardiac remodeling in the hypertrophied heart.
Iwata K; Sawa Y; Kitagawa-Sakakida S; Kawaguchi N; Matsuura N; Nakamura T; Matsuda H
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):719-25. PubMed ID: 16153919
[TBL] [Abstract][Full Text] [Related]
7. Induction of cardiac fibrosis by transforming growth factor-beta(1).
Lijnen PJ; Petrov VV; Fagard RH
Mol Genet Metab; 2000; 71(1-2):418-35. PubMed ID: 11001836
[TBL] [Abstract][Full Text] [Related]
8. Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair.
Yano T; Miura T; Whittaker P; Miki T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ohori K; Shimamoto K
J Am Coll Cardiol; 2006 Feb; 47(3):626-34. PubMed ID: 16458148
[TBL] [Abstract][Full Text] [Related]
9. N-methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism.
Yamamoto K; Takahashi Y; Mano T; Sakata Y; Nishikawa N; Yoshida J; Oishi Y; Hori M; Miwa T; Inoue S; Masuyama T
Eur Heart J; 2004 Jul; 25(14):1221-9. PubMed ID: 15246640
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.
Sugano Y; Anzai T; Yoshikawa T; Maekawa Y; Kohno T; Mahara K; Naito K; Ogawa S
Cardiovasc Res; 2005 Feb; 65(2):446-56. PubMed ID: 15639484
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts.
Ogata T; Miyauchi T; Sakai S; Irukayama-Tomobe Y; Goto K; Yamaguchi I
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():284S-288S. PubMed ID: 12193105
[TBL] [Abstract][Full Text] [Related]
12. In vivo protein synthetic rates of atrial, ventricular, and pulmonary tissue proteins in aortic constriction, goldblatt, and bromoethylamine models of hypertension.
Siddiq T; Patel VB; Sherwood R; Richardson PJ; Preedy VR
Exp Mol Pathol; 2001 Feb; 70(1):19-30. PubMed ID: 11170787
[TBL] [Abstract][Full Text] [Related]
13. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats.
Suzuki T; Akasaka Y; Namiki A; Ito K; Ishikawa Y; Yamazaki J; Ishii T
J Hypertens; 2008 Dec; 26(12):2436-44. PubMed ID: 19008723
[TBL] [Abstract][Full Text] [Related]
16. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
[TBL] [Abstract][Full Text] [Related]
17. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
[TBL] [Abstract][Full Text] [Related]
18. Remodeling of the cardiac extracellular matrix differs between volume- and pressure-overloaded ventricles and is specific for each heart valve lesion.
Piper C; Schultheiss HP; Akdemir D; Rudolf J; Horstkotte D; Pauschinger M
J Heart Valve Dis; 2003 Sep; 12(5):592-600. PubMed ID: 14565712
[TBL] [Abstract][Full Text] [Related]
19. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart.
Heymans S; Schroen B; Vermeersch P; Milting H; Gao F; Kassner A; Gillijns H; Herijgers P; Flameng W; Carmeliet P; Van de Werf F; Pinto YM; Janssens S
Circulation; 2005 Aug; 112(8):1136-44. PubMed ID: 16103240
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant probucol attenuates myocardial oxidative stress and collagen expressions in post-myocardial infarction rats.
Zhou SX; Zhou Y; Zhang YL; Lei J; Wang JF
J Cardiovasc Pharmacol; 2009 Aug; 54(2):154-62. PubMed ID: 19568179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
